Evidence map›Paper›PMID 25512795›Full record

ReviewWorld journal of diabetes2014

Diabetes mellitus in Nigeria: The past, present and future.

Anthonia Okeoghene Ogbera, Chukwuma Ekpebegh

Open access · bronzeAbstract readReview
In one paragraph

Review in World journal of diabetes, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 42 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
42citing papers in PubMed, 1 pooled it
4.7field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

42 citing papers in PubMed, 1 synthesis or guideline pooled it, 161 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Article
  4. Article
  5. Edible mushroom (Anatomy & cell biology · 2024
    Article
  6. Article
  7. Article
  8. Article
  9. Diabetes Mellitus as a risk factor for stroke among Nigerians: A systematic review and meta-analysis.International journal of cardiology. Cardiovascular risk and prevention · 2023
    Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Polyphenolic-rich extracts ofJournal of diabetes and metabolic disorders · 2020
    Article
  17. Review
  18. Article
  19. Oxidative medicine and cellular longevity · 2020
    Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

Anthonia Okeoghene OgberaAnthonia Okeoghene Ogbera, Department of Medicine, Endocrine Unit, Lagos State University College of Medicine, PMB 21266, Ikeja, Lagos State, Nigeria.
Chukwuma EkpebeghAnthonia Okeoghene Ogbera, Department of Medicine, Endocrine Unit, Lagos State University College of Medicine, PMB 21266, Ikeja, Lagos State, Nigeria.
Lagos State University · NG

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Diabetes mellitus (DM) is a diverse group of metabolic disorders that is often associated with a high disease burden in developing countries such as Nigeria. In the early nineties, not much was known about DM in Nigeria and traditionally, people related DM to "curses" or "hexes" and diagnosis was made based on blood or urinary tests for glucose. Currently, oral hypoglycaemic agents but not insulin are readily accessible and acceptable to persons with DM. The cost of diabetes care is borne in most instances by individuals and often payment is "out of pocket"-this being a sequel of a poorly functional national health insurance scheme. An insulin requiring individual on a minimum wage would spend 29% of his monthly income on insulin. Complementary and alternative medicines are widely used by persons with DM and form an integral component of DM care. Towards reducing the burden of DM in Nigeria, we suggest that there be concerted efforts by healthcare professionals and stakeholders in the health industry to put in place preventative measures, a better functioning health insurance scheme and a structured DM program.

Indexed as

BurdenCostsDiabetes mellitusInsulinPrevalence

Identifiers

PMID25512795
PMCPMC4265879
OpenAlexW1971840133

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.